Congratulations to Immusoft on becoming the first Breakout Labs portfolio company to receive funding from Founder Fund’s new initiative, FF Science.
A few weeks ago, we brought our 19 portfolio companies together for a workshop at The Box SF. Early on, given the diversity of disciplines and business models (antimatter space propulsion to man-made meat), we…
Breakout Labs company Siva Therapeutics will have its first peer-reviewed publication in the open-access Journal of Nanomaterials.